Sonexa Therapeutics, Inc. Report issue

For profit Phase 2
Founded: San Diego CA United States (2007)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2009
NCT00842673
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

st101 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Essential Tremor (Phase 2)

Tremor (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1